Daniel Loeb's position in United Therapeutics is currently worth $58.8 Million. That's 0.83% of their equity portfolio (23rd largest holding). Daniel Loeb acquired their 250 Thousand shares between 2006 and 2007. So far they never sold any shares in the company. The stake costed the investor $18.8 Million, netting the investor a gain of 213% so far.